04:20 AM EDT, 03/27/2026 (MT Newswires) -- Anthony Mancini, Chief Global Commercialization Officer, on March 25, 2026, sold 37,450 shares in Revolution Medicines ( RVMD ) for $3,578,821. Following the Form 4 filing with the SEC, Mancini has control over a total of 54,400 common shares of the company, with 54,400 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/xslF345X05/form4.xml